HBK INVESTMENTS L P - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$11,784,000
-39.9%
947,249
-33.9%
0.11%
-36.0%
Q3 2016$19,622,000
+77.6%
1,433,300
-4.1%
0.18%
+119.8%
Q2 2016$11,050,000
+121.8%
1,495,300
+91.8%
0.08%
+68.8%
Q1 2016$4,983,000
-4.3%
779,800
-6.4%
0.05%0.0%
Q4 2015$5,209,000
-20.5%
833,451
-25.7%
0.05%
-27.3%
Q3 2015$6,553,000
+556.6%
1,122,100
+829.7%
0.07%
+560.0%
Q2 2015$998,000120,7000.01%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders